Loading...

Martin Kabongo

TitleClinical Professor
InstitutionUniversity of California San Diego
DepartmentFamily Medicine and Public Health
Address200 W. Arbor Drive #8217
San Diego CA 92103
Phone858-657-7750
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Kabongo's global health research interests center around the long term impacts of short trip interventions in targeted populations abroad.


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Heyward WL, Kyle M, Blumenau J, Davis M, Reisinger K, Kabongo M, Bennett S, Janssen RS, Namini H, Martin JT. Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age. Vaccine. 2013 Nov 04; 31(46):5300-5. PMID: 23727002.
      View in: PubMed
    2. Peters W, Brandl JR, Lindbloom JD, Martinez CJ, Scallan CD, Trager GR, Tingley DW, Kabongo M, Tucker SN. Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-? T cell responses in humans. Vaccine. 2013 Mar 25; 31(13):1752-8. PMID: 23357198.
      View in: PubMed
    3. Talaat KR, Greenberg ME, Lai MH, Hartel GF, Wichems CH, Rockman S, Jeanfreau RJ, Ghosh MR, Kabongo M, Gittleson C, Karron RA. A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults. J Infect Dis. 2010 Nov 01; 202(9):1327-37. PMID: 20874515.
      View in: PubMed
    4. Smith LR, Wloch MK, Ye M, Reyes LR, Boutsaboualoy S, Dunne CE, Chaplin JA, Rusalov D, Rolland AP, Fisher CL, Al-Ibrahim MS, Kabongo M, Steigbigel R, Belshe RB, Kitt ER, Chu AH, Moss RB. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin. Vaccine. 2010 Mar 16; 28(13):2565-72. PMID: 20117262.
      View in: PubMed
    5. Schiff GD, Hasan O, Kim S, Abrams R, Cosby K, Lambert BL, Elstein AS, Hasler S, Kabongo M, Krosnjar N, Odwazny R, Wisniewski MF, McNutt RA. Diagnostic error in medicine: analysis of 583 physician-reported errors. Arch Intern Med. 2009 Nov 09; 169(20):1881-7. PMID: 19901140.
      View in: PubMed